Global Patient Monitoring Devices Market Set to Double by 2032

2025-03-28 digitalcare

Global, Friday, 28 March 2025.
The global patient monitoring devices market is projected to reach USD 93.53 billion by 2032 from USD 48.03 billion in 2023, fueled by technological advancements and rising chronic disease prevalence.

Market Growth Drivers and Regional Dynamics

The remarkable expansion represents a compound annual growth rate (CAGR) of 7.71% from 2024 to 2032 [1]. This growth is primarily driven by technological advancements in AI-driven healthcare solutions and the increasing prevalence of chronic diseases worldwide [1]. North America currently dominates the market, holding a substantial 40% of global revenue share in 2023 [1], while the Asia-Pacific region is positioned for the highest growth rate during the forecast period [1][3].

U.S. Market Leadership and Innovation

The United States maintains a particularly strong position, with its remote patient monitoring market expected to reach USD 29.13 billion by 2030 from USD 14.15 billion in 2024 [2]. This robust growth is supported by demographic shifts, as the U.S. population aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050 [2]. A recent development highlighting this momentum is Abbott’s January 2025 introduction of Lingo, an innovative wearable biosensor for continuous glucose monitoring [1].

Digital Health Integration and Market Segmentation

The digital health sector is experiencing unprecedented growth, with projections showing an expansion from USD 427.24 billion in 2025 to USD 1,500.69 billion by 2032 [6]. In the specific context of patient monitoring, hospitals currently lead the market with 49.6% of revenue share [1], while the home care segment is poised for substantial growth due to increasing demand for remote monitoring solutions [1][3].

Technological Innovation and Future Outlook

The market is witnessing significant technological advancement, particularly in AI-enabled monitoring solutions. The AI in telemedicine segment alone is expected to reach USD 90.70 billion by 2030 [7]. Recent innovations include the March 2025 launch of AvaSure’s AI-powered virtual care assistant, Vicky [7], demonstrating the industry’s rapid technological evolution. The wearable technology market, valued at USD 84.2 billion in 2024 [8], further supports this growth trajectory, with 41% of U.S. consumers now owning wearable devices [8].

Bronnen

remote monitoring chronic diseases